Skip to main content

Table 6 No. of patients and institutions treated with perioperative denosumab for GCTBa

From: Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

Timing of perioperative denosumab

No. of patients (%)

No. of institutions (%)

Preoperative only

21 (53%)

10 (63%)

Postoperative only

9 (23%)

5 (31%)

Both pre- and postoperative

10 (25%)

5 (31%)

Total

40

16*

  1. aGCTB, giant cell tumor of bone
  2. *Some institutions performed denosumab at different timing